|
2017 |
Where published |
Association of British Clinical Diabetologists - Renal
Association (ABCD-RA) Clinical Practice Guidelines for
Management of Lipids in Adults with Diabetes Mellitus and
Nephropathy and/or Chronic Kidney Disease |
Association of British
Clinical Diabetologists ABCD website - see link opposite.
See also
PB Mark, PH Winocour, C Day. Br. J. Diabetes
2017;17:64-72. A data collection chart for audit of lipid
management can be downloaded by clicking
here. |
ABCD position statement on standards of care for management
of adults with type 1 diabetes |
Association of British Clinical Diabetologists
ABCD website - see link opposite. |
2016 |
|
ABCD position statement on the risk of diabetic ketoacidosis
with the use of sodium-glucose cotransporter-2 inhibitors |
Association of British Clinical Diabetologists
ABCD website - see link opposite. |
ABCD position statement on standards of care for management
of adults with type 1 diabetes - this has been superseded by
the 2017 version - see above |
Association of British Clinical Diabetologists
ABCD website - see link opposite. |
2015 |
|
Care coordination/ management for adults with type 1
diabetes - joint position statement with Diabetes UK |
Association of British Clinical Diabetologists
ABCD website - see link opposite. |
2013 |
|
ABCD position statement on GLP-1 based therapies and
pancreatic damage - full statement |
Association of British Clinical Diabetologists
ABCD website - see link opposite. Also published as:
REJ Ryder, JA McKnight, AD Blann, K Dhatariya, R Gregory, AM
Robinson, S Rowles, P Sharp. PH Winocour, C Walton
Practical Diabetes 2013; 30(9): 388-391 |
ABCD position statement on GLP-1 based therapies and
pancreatic damage - summary statement |
Association of British Clinical Diabetologists
ABCD website - see link opposite |
ABCD response to the Future Hospital Commission |
Association of British Clinical Diabetologists
ABCD website - see link opposite |
2012 |
|
Type 1 diabetes and specialist care |
P Sharp and C Walton
Practical Diabetes 2012; 29(8): 1-2 |
2011 |
|
Diabetes and end of life care |
S Rowles, A Kilvert, A Sinclair
Pract Diab Int 2011; 28(1): 26-27 |
2010 |
|
Recommendations following suspension
of rosiglitazone (Avandia) |
N Goenka, A Roberts, S Rowles, REJ Ryder, PH Winocour
Pract Diab Int 2010; 27(9):
374-376a |
Management of hypogonadal males with type 2
diabetes |
K Dhatariya, D Nagi, TH Jones
Pract Diab Int 2010; 27(9): 408-412 |
Haemoglobin A1c for the diagnosis of diabetes |
ES Kilpatrick and PH Winocour
Pract Diab Int 2010; 27(7): 306-310 |
Physical activity and exercise in
diabetes |
D Nagi and I Gallen
Pract Diab Int 2010; 27(4): 158-163a |
Continuous glucose monitoring: use of glucose
sensing in outpatient clinical diabetes care |
PJ Hammond, SA Amiel, CM Dayan, D Kerr, JC Pickup, JAM Shaw, FM
Campbell, SA Greene and PC Hindmarsh
Pract Diab Int 2010; 27(2): 66-68 |
2009 |
|
Incretin mimetics and DPP-4 inhibitors |
CMB Edwards and PH Winocour
Pract Diab Int 2009; 26(5): 191-194 |
Influenza Pandemic (including Swine Flu) and Diabetes |
K Shaw. Contingency planning and medical management :
implications & implementation considerations for the UK.
Published only on this website |
2007 |
|
Lipid modifying drug therapy in diabetes |
MD Feher and PH Winocour
Pract Diab Int 2007; 24(9): 458-462 |
Screening for gestational diabetes mellitus |
S Robinson and A Dornhorst
Pract Diab Int 2007; 24(4): 192-195 |
2006 |
|
ABCD Diabetes Specialist Surveys |
P Winocour et al
Various places - see link |
Insulin pumps |
P Hammond, S Boardman and RH Greenwood
Pract Diab Int 2006; 23(9): 235-400 |
Management of hyperglycaemic emergencies in adults |
MW Savage and A Kilvert
Pract Diab Int 2006; 23(5): 227-231
Diabetic ketoacidosis guideline updated in 2010 - see link |
2005 |
|
Joint Position Statement on Access to high quality care for
people with diabetes - Diabetes UK and ABCD |
Association of British Clinical Diabetologists
and Diabetes UK
ABCD website - see link |
2004 |
|
Diabetic retinal screening following
publication of the NSF for England and Wales |
C Walton, A Kilvert, REJ Ryder, S Olcak, D Nagi and A Robinson
Pract Diab Int 2004; 21(9): 349-351 |
Glitazones |
ER Higgs, AJ Krentz
Pract Diab Int 2004; 21(8): 293-295 |
ABCD position papers: introduction |
RH Greenwood, K Shaw, Peter Winocour
Pract Diab Int 2004; 21(8): 293-293 |
Will NICE guidelines on the management of Type 2 diabetes
improve diabetes care? |
PH Winocour, K Shaw, RH Greenwood
Pract Diab Int 2004; 21(1): 3-6 |
2002 |
|
National Service Framework (NSF) Standards |
PH Winocour, RH Greenwood and J Wales
ABCD website - see link |
General practitioners with a special interest in diabetes |
RH Greenwood
ABCD website - see link |
2000 |
|
ABCD Diabetes Specialist Surveys |
P Winocour et al
Various places - see link |
Working to support high quality diabetes care in the
UK |